Kailera IPO interview: CEO Renaud talks biotech market, China and obesity pipeline
THE SO WHAT
A $625M Nasdaq IPO around an obesity pipeline backed by Bain Capital Life Sciences shows public markets still reward clear, single-thesis biotech stories. If you’re building AI-for-bio, align your narrative to specific disease economics and regional strategy—not generic “platform” language.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechWorld expands its Tinder partnership and partners with Zoom and others to verify human users, as it continues its pivot from crypto to identity verification (Maxwell Zeff/Wired)
World’s pivot from crypto to human verification for Tinder and Zoom is the real business model: identity as a networked utility, not a token experiment. Any product with user-generated content or payments now has to decide whether to plug into these proof-of-humanity rails or build their own.
Deep & Emerging TechThe historic surge in chip stocks highlights Micron’s valuation, and a related warning
A 34% run in the semiconductor ETF in 13 days says public markets are now pricing AI hardware like a secular commodity supercycle, not a cyclical. If you’re an operator, assume your chip and memory vendors will prioritize capacity commitments and strategic partners over discounting — lock in supply and terms before the next repricing.
Deep & Emerging TechNew CDC pick Schwartz is praised by public health pros
A stabilizing CDC with a director who has operational and uniformed service experience means public health guidance is likely to get more predictable and enforcement-minded. Healthcare and biotech operators should expect tighter alignment between federal recommendations and payer/provider behavior — compliance windows will shrink.
Deep & Emerging Tech'They mopped the floor with me and pulled every childish game they could': Disgruntled researcher releases second major Windows zero-day — claims Microsoft 'would ruin my life, and they did'
Independent researchers dropping Windows Defender zero-days out of frustration is a reminder that your security exposure now includes the emotional state of unpaid contributors. Treat bug bounty and disclosure as strategic vendor relationships — not ticket queues — or assume your blue team roadmap will be set by public exploits, not your CISO.